Genmab — Marts 2025
-
@lahn1 Tak for input. Vi får forhåbentlig snart lidt mere at vide.
-
@Anders_ Det svarer fint overens med min hukommelse. Tak skal du have.
-
TIVDAK
(tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy https://ir.genmab.com/news-releases/news-release-details/tivdakr-tisotumab-vedotin-approved-japan-ministry-health-labour -
That's excellent news E L. We'll probably end at around 1200 today

-
True. Today
-
is very positive in my opinion as well!
-
Genmab får japansk godkendelse af middel til behandling af livmoderhalskræft https://proinvestor.com/investornyt/1296057/genmab-far-japansk-godkendelse-af-middel-til-behandling-af-livmoderhalskraeft
-
Omsætningen ser ikke ud til at være højere end normalt, så det er nok glædeligvis ikke tilbagekøbet, der sender kursen i grønt i modsætning til det øvrige marked.
-
-
Ugens grafik 02: Investorerne forlader stadig biotek https://proinvestor.com/investornyt/1296485/ugens-grafik-02-investorerne-forlader-stadig-biotek
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind